Global Pigmentation Disorder Therapeutics Market 2018-2022
About Pigmentation Disorder
Pigmentation therapeutics include the medications that are used to improve the pigmentation of the skin. Changes in the concentration of melanin lead to different types of pigmentation disorders. Mainly, topical drugs that are available in the form of creams, ointments, and gels are used in the treatment of pigmentation disorders.
Technavio’s analysts forecast the Global Pigmentation Disorder Therapeutics Market to grow at a CAGR of 6.83% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the pigmentation disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of pigmentation disorder therapeutics across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Pigmentation Disorder Therapeutics Market 2018-2022
Technavio recognizes the following companies as the key players in the global pigmentation disorder therapeutics market: Allergan, Nestlé, Pierre Fabre, SkinCeuticals, and Vivier.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the increased development of products for skin pigmentation treatment. The global autism spectrum disorder therapeutics market is likely to be driven by driven by growing number of products being launched for skin pigmentation treatment.”
According to the report, one driver influencing this market is the increasing awareness about pigmentation disorders. The global pigmentation disorder therapeutics market is likely to be driven by rise in awareness of pigmentation disorders.
Further, the report states that one challenge affecting this market is the fragmented market. The global pigmentation disorder therapeutics market is a fragmented market due to the presence of small and large established vendors.